Quick answer
Regal Rexnord Corp (RRX) reported revenue of $5.93B and net income of $279.5M for the fiscal year ended 2025-12-31, down 1.6% from $6.03B the year before, per its 10-K filed with the SEC on 2026-02-20. Long-term debt stood at $4.82B.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $5.93B | $279.5M | $4.82B |
| 2024 (FY ending 2024-12-31) | $6.03B | $196.2M | $5.50B |
| 2023 (FY ending 2023-12-31) | $6.25B | -$57.4M | $6.38B |
| 2022 (FY ending 2022-12-31) | $5.22B | $488.9M | $2.02B |
| 2022 (FY ending 2022-01-01) | $3.81B | $229.6M | $1.92B |
| 2021 (FY ending 2021-01-02) | $2.91B | $187.7M | $1.07B |
| 2019 (FY ending 2019-12-28) | $3.24B | $238.9M | $1.14B |
| 2018 (FY ending 2018-12-29) | $3.65B | $231.2M | $1.31B |
| 2017 (FY ending 2017-12-30) | $3.36B | $213.0M | $1.14B |
| 2016 (FY ending 2016-12-31) | $3.22B | $203.4M | $1.41B |
Related
- RPM revenue, net income and debt history (RPM International Inc.)
- RPRX revenue, net income and debt history (Royalty Pharma plc)
- RRC revenue, net income and debt history (Range Resources Corp)
- RS revenue, net income and debt history (Reliance, Inc.)
- RSG revenue, net income and debt history (Republic Services, Inc.)
- RTX revenue, net income and debt history (Rtx Corporation)
- RVMD revenue, net income and debt history (Revolution Medicines, Inc.)
- RVTY revenue, net income and debt history (Revvity, Inc)
Last updated 2026-10-16. Data only, not financial or tax advice.